Physician

Bryan James Bienvenu, MD

According to 2025 Medicare claims, Bryan Bienvenu, MD (NPI: 1932121795) practices hematology/oncology in the Baton Rouge, LA market, with the plurality of this provider's patient population coming from E. Baton Rouge, LA. This provider's primary affiliated billing organization is MARY BIRD PERKINS CANCER CENTER (NPI: 1295833580; TIN: 237010520) and primary practice location at 70809-3482. Bienvenu is affiliated with the Ochsner Senior Care Network, LLC (ACO ID: A5662), participating under the MSSP model.

Bienvenu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 594 traditional Medicare patients, billed 134,049 HCPCS/CPT codes, and received $2,494,087 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 5,139 prescription claims across 550 beneficiaries totaling $5,464,161 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 161 claims. Open Payments data shows 27 records totaling $7,482. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $110,991 to $2,494,087. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $754,055 to $5,464,161. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $3,274 to $4,083.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	417	1,830	$110,991
2016	395	1,592	$91,361
2017	404	1,583	$105,019
2018	419	1,710	$114,816
2019	404	1,741	$121,942
2020	355	1,359	$95,523
2021	324	1,127	$106,131
2022	389	77,945	$1,621,441
2023	627	106,323	$2,000,115
2024	594	134,049	$2,494,087

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	320	2,982	$754,055
2016	299	2,787	$1,132,349
2017	323	2,824	$1,661,394
2018	357	3,280	$2,215,280
2019	378	3,289	$2,339,558
2020	376	3,680	$2,930,958
2021	392	3,921	$3,714,234
2022	404	4,517	$3,593,732
2023	460	4,795	$3,775,357
2024	550	5,139	$5,464,161

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	70	$5,011
2016	N/R	73	$5,129
2017	N/R	46	$4,541
2018	N/R	62	$6,737
2019	N/R	100	$14,200
2020	N/R	110	$9,855
2021	N/R	114	$10,720
2022	N/R	72	$6,241
2023	N/R	82	$9,077
2024	12	161	$20,618

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	60	60	$155
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	224	833	$131
96413	Administration of chemotherapy into vein, 1 hour or less	56	286	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	369	792	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	100	127	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	73	2,064	$959,332
Revlimid	Lenalidomide	28	784	$484,360
Ayvakit	Avapritinib	12	360	$468,549
Brukinsa	Zanubrutinib	28	840	$415,422
Lenvima	Lenvatinib Mesylate	15	450	$357,735

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	60	$10,812
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	12	63	$5,870
B4150	Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$2,086
B4036	Enteral feeding supply kit; gravity fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	15	$1,793
E0776	Iv pole	Y	N/R	12	$57

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$482	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$7,000	Celgene Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bryan James Bienvenu, MD?

Tedicare shows public-source Medicare data for Bryan James Bienvenu, MD (NPI 1932121795), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bryan James Bienvenu, MD have ACO affiliation data?

Bryan James Bienvenu, MD is shown with ACO affiliation data for Ochsner Senior Care Network, LLC (MSSP, ACO ID A5662).

What billing organization is linked to Bryan James Bienvenu, MD?

Bryan James Bienvenu, MD is linked to MARY BIRD PERKINS CANCER CENTER (billing NPI 1295833580) in the available physician profile data.

Does Bryan James Bienvenu, MD have Open Payments data?

Bryan James Bienvenu, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.